XTX Topco’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,626
Closed -$1.02M 2592
2025
Q1
$1.02M Buy
23,626
+11,409
+93% +$578K 0.05% 553
2024
Q4
$686K Sell
12,217
-15,155
-55% -$943K 0.06% 516
2024
Q3
$1.86M Buy
27,372
+1,263
+5% +$71.3K 0.13% 163
2024
Q2
$1.1M Buy
26,109
+18,662
+251% +$1.03M 0.09% 321
2024
Q1
$514K Buy
7,447
+1,853
+33% +$117K 0.07% 473
2023
Q4
$414K Sell
5,594
-3,273
-37% -$215K 0.09% 380
2023
Q3
$605K Sell
8,867
-2,040
-19% -$173K 0.1% 289
2023
Q2
$1.02M Buy
+10,907
New +$851K 0.18% 79
2022
Q4
Sell
-8,670
Closed -$282K 1242
2022
Q3
$282K Buy
+8,670
New +$357K 0.07% 544
2022
Q1
Sell
-2,897
Closed -$225K 748
2021
Q4
$225K Buy
+2,897
New +$256K 0.13% 322
2021
Q2
Sell
-3,431
Closed -$452K 885
2021
Q1
$452K Buy
+3,431
New +$470K 0.22% 124

Other funds holding EXAS

XTX Topco's EXAS Position: Q2 2025 in Review

XTX Topco sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 23,626 shares — an estimated $1.02M sold.

XTX Topco first reported a position in EXAS in Q1 2021 and held it in 11 quarters. The position peaked at $1.86M in Q3 2024. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • XTX Topco reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 23,626 Exact Sciences shares in Q2 2025, an estimated $1.02M.
  • XTX Topco first reported a position in Exact Sciences in Q1 2021 and held it in 11 quarters.
  • XTX Topco's Exact Sciences position peaked at $1.86M in Q3 2024.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.